Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when he plans to implement the recommendations outlined in the Cumberlege Review with respect to the drug Primodos.

Our sympathies remain with those who believe they were harmed by hormone pregnancy tests, such as Primodos.

Recommendation 4 of the Independent Medicines and Medical Devices Safety Review, also known as the Cumberlege Review, specifically mentions hormone pregnancy tests, recommending that separate redress schemes be set up for each of the interventions examined by the Review, namely hormone pregnancy tests, sodium valproate and pelvic mesh. As a follow up to this recommendation, the Patient Safety Commissioner was asked to investigate and provide advice on options for redress for those affected by sodium valproate and pelvic mesh. The Government is carefully considering the Patient Safety Commissioner’s recommendations.

The Patient Safety Commissioner was not asked to look at Primodos as part of this work, because the available scientific evidence does not support a causal association between the use of hormone pregnancy tests such as Primodos and adverse outcomes in pregnancy. The Government is committed to reviewing any new scientific evidence which may come to light.